CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
147 hedge funds and large institutions have $358M invested in Clovis Oncology, Inc. in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
-6
Holders Change %
-3.92%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
36
Increased
36
Reduced
50
Closed
41
Calls
$114M
Puts
$118M
Net Calls
-$3.65M
Net Calls Change
-$8.25M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$38.2M |
| 2 |
PA
2
Pinnacle Associates
New York
|
$6.55M |
| 3 |
AG
3
Artal Group
Luxembourg
|
$10.4M |
| 4 |
PAI
4
Palo Alto Investors
Palo Alto,
California
|
$52.7M |
| 5 |
5
Jane Street
New York
|
$2.67M |
Top Sellers
| 1 |
ECP
1
Elk Creek Partners
Denver,
Colorado
|
$5.99M |
| 2 |
2
Morgan Stanley
New York
|
$6.2M |
| 3 |
3
BlackRock
New York
|
$35.6M |
| 4 |
RG
4
Redmile Group
San Francisco,
California
|
$0 |
| 5 |
5
D.E. Shaw & Co
New York
|
$4.45M |
